• Müller Cell PEDF and Angiopoietin Signaling in Retinal Neuro

  2026-07-27

  This study clarifies how Müller cell-derived pigment epithelium-derived factor (PEDF) integrates with angiopoietin (Ang-1, Ang-2) signaling to control retinal neuron survival. By dissecting cell-specific Tie-2/PI3K/Akt pathways and PEDF regulation, the work advances understanding of retinal neuroprotection mechanisms and highlights molecular targets for future experimental research.

• Cell Division Refines Tissue Boundaries in Drosophila Embryo

  2026-07-26

  Castle et al. (2026) provide evidence that cell divisions in Drosophila embryos both challenge and sharpen tissue boundaries by modulating tissue fluidity and mechanical tension. These findings clarify longstanding questions in developmental biology and have implications for studying boundary integrity in disease and cancer models.

• Calcitriol (SKU B2141): Reliable Solutions for Cell Assays

  2026-07-25

  This article addresses persistent challenges in cell viability, proliferation, and signaling assays by applying Calcitriol (SKU B2141) as a dependable, data-validated research reagent. Grounded in current literature and best practices, it offers scenario-driven guidance for optimizing protocols and data reliability in immune modulation and reproductive signaling research.

• Optimizing Oxaliplatin Workflows in Cancer Chemotherapy Rese

  2026-07-24

  Oxaliplatin stands out as a platinum-based chemotherapeutic agent with unique efficacy and protocol flexibility across preclinical models. This article delivers advanced, actionable insights for maximizing reproducibility, overcoming resistance, and troubleshooting experimental challenges using APExBIO’s Oxaliplatin SKU A8648.

• CA-074 Cathepsin B Inhibitor: Unveiling Roles Beyond Cancer

  2026-07-24

  Explore the scientific depth of CA-074, a potent cathepsin B inhibitor, with a unique focus on cross-kingdom protease biology and protocol optimization. This article provides actionable insights for researchers seeking precision in disease modeling and plant senescence studies.

• Anemoside B4 Suppresses Colitis via CD1d-Dependent NLRP3 Blo

  2026-07-23

  This preprint reveals that Anemoside B4 mitigates DSS-induced colitis by inhibiting CD1d-dependent NLRP3 inflammasome activation in macrophages. The study provides mechanistic insight into the AKT-STAT1-PRDX1-NF-κB axis, highlighting new avenues for inflammation research and therapeutic intervention in ulcerative colitis.

• CHIR-99021 (CT99021): Advancing Spatial Cell Fate with GSK-3

  2026-07-23

  Discover how CHIR-99021 (CT99021) empowers spatial cell fate engineering and morphogenesis modeling through precise GSK-3 inhibition. This article provides a deep dive into protocol parameters, mechanistic insights, and practical assay design for advanced stem cell and organoid research.

• ALDH2 Activation Extends Cardiomyocyte Proliferation to Dela

  2026-07-22

  The referenced study reveals that activating ALDH2 in mice prolongs the window of cardiomyocyte proliferation, significantly delaying the onset of heart failure induced by ventricular pressure overload. These findings provide a mechanistic foundation for targeting ALDH2 in cardiac regeneration and highlight the translational potential of ALDH2 activators for preclinical cardioprotection research.

• Thiazovivin: ROCK Inhibitor Protocols for Stem Cell Research

  2026-07-22

  Thiazovivin is a selective ROCK inhibitor optimized for workflows requiring efficient induced pluripotent stem cell (iPSC) generation and improved human embryonic stem cell (hESC) survival. It is not suitable for diagnostic or therapeutic use. Proper handling and application are essential to preserve its activity in stem cell research protocols.

• Glabridin-Gold(I) Complex Enhances Antitumor Immunity via Tr

  2026-07-21

  This study presents a novel glabridin-gold(I) complex (6d) that synergistically targets thioredoxin reductase and MAPK pathways to modulate the tumor immune microenvironment, enhancing antitumor immune responses. Its dual action reduces immunosuppression and increases tumor immunogenicity, offering new insights for combination immunotherapies.

• Veratridine as a Voltage-Gated Sodium Channel Opener: Applie

  2026-07-21

  Veratridine stands out as a precise voltage-gated sodium channel opener, offering unique advantages in both cardiac and neurophysiology research. This article demystifies its experimental workflows, troubleshooting, and advanced applications—bridging sodium channel dynamics with disease modeling for reproducible, high-impact results.

• Next-Generation mRNA Tools: Translational Impact of EZ Cap™

  2026-07-20

  This thought-leadership article explores the mechanistic advances and translational strategies enabled by EZ Cap™ EGFP mRNA (5-moUTP), focusing on experimental rigor, immune modulation, and the evolving landscape of mRNA delivery for gene expression and in vivo imaging. Drawing on recent breakthroughs and pivotal studies, we highlight how APExBIO’s Cap 1-structured, 5-moUTP-modified reporter mRNA is redefining standards in translational workflows, bridging fundamental insight with practical guidance for researchers.

• Tiamulin (Thiamutilin): Protocols and Innovations in Veterin

  2026-07-20

  Tiamulin (Thiamutilin) stands out as a dual-action antibiotic and anti-inflammatory agent, offering high potency against Mycoplasma and Gram-positive infections in pigs and poultry. This guide delivers data-backed protocols, advanced troubleshooting, and comparative insights for maximizing Tiamulin’s impact in both in vitro and in vivo research workflows.

• JNJ-10198409: Applied Workflows for PDGF Receptor Inhibition

  2026-07-19

  JNJ-10198409 is a nanomolar-potency platelet-derived growth factor receptor inhibitor that empowers reproducible angiogenesis and tumor growth studies. This guide details advanced workflows, troubleshooting strategies, and insight-driven protocol parameters to maximize the impact of JNJ-10198409 from APExBIO in translational research settings.

• ERK Inhibition Protects Neuronal Cells via Mitochondrial Dyn

  2026-07-18

  Yuan et al. elucidate how ERK inhibition mitigates autophagy and mitochondrial fragmentation, thus protecting SH-SY5Y neuronal cells from oxygen-glucose deprivation/reoxygenation (OGD/R) injury. Their mechanistic insights offer a new perspective on targeting ERK-Drp1/Mfn2 pathways for cerebral ischemia-reperfusion injury (CIRI) intervention.

451 records 10/31 page Previous Next First page 上5页 678910 下5页 Last page